Improving neurological and mental health outcomes for children with prenatal drug exposure.  Oei JL.  Semin Fetal Neonatal Med. 2024 Nov 7:101557. doi: 10.1016/j.siny.2024.101557. Epub ahead of print. PMID: 39537449. https://www.sfnmjou…

Health outcomes in children with prenatal opioid exposure with and without neonatal abstinence syndrome in the first seven years of life: An observational cohort study. Lambert J, Arter S, Duah H, Xavier T, Sprague JE.  J Nurs Scholarsh. 2024…

Impact of a qualitative assessment approach for neonatal abstinence syndrome management: experience of a European reference center.  Cortez Ferreira M, Moura Figueiredo A, Pitorra J, Mesquita da Silva J.  Ital J Pediatr. 2024 Oct 29;50(1…

Services for perinatal patients with opioid use disorder: a comprehensive Baltimore City-wide 2023 assessment.  Ratner JA, Kirschner JH, Spencer B, Terplan M.  Addict Sci Clin Pract. 2024 Oct 15;19(1):73. doi: 10.1186/s13722-024-00507-0…

Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?  Marc B, Marion D, François B, Lakshmipriya L.  Am J Addict. 2024 Sep 29. doi: 10.1111/ajad.13652. Epub ahead of print. PMID: 39342492. https:/…

Eat, Sleep, Console model for neonatal opioid withdrawal syndrome: a meta-analysis.  Chu L, Liu X, Xu C.  Front Pediatr. 2024 Aug 16;12:1416383. doi: 10.3389/fped.2024.1416383. PMID: 39220152; PMCID: PMC11362100. https://www.ncbi.nlm.ni…